References
- Aoki J, Ikari Y. Cardiovascular disease in patients with end-stage renal disease on hemodialysis. Ann Vasc Dis. 2017;10(4):327-37. https://doi. org/10.3400/avd.ra.17-00051.
- Isaac T, Gilani S, Kleiman NS. When prevention is truly better than cure: contrast-associated acute kidney injury in percutaneous coronary intervention. Methodist Debakey Cardiovasc J. 2022;18(2):73-85. https://doi.org/10.14797/mdcvj.1136.
- Yang Y, George KC, Luo R, Cheng Y, Shang W, Ge S, et al. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol. 2018;19(1):374. https://doi.org/10.1186/s12882-018-1161-5.
- Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491-9. https://doi.org/10.1056/NEJMoa021833.
- Caracciolo A, Scalise RFM, Ceresa F, Bagnato G, Versace AG, Licordari R, et al. Optimizing the outcomes of percutaneous coronary intervention in patients with chronic kidney disease. J Clin Med. 2022;11(9):2380. https://doi.org/10.3390/jcm11092380.
- Khan SF, Kalantari K. The use of iodinated contrast media in patients with end-stage renal disease. Semin Dial. 2014;27(6):607-10. https://doi.org/10.1111/sdi.12268.
- Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2009;2(7):645-54. https://doi.org/10.1016/j.jcin.2009.05.002.
- Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology. 2009;250(1):68-86. https://doi.org/10.1148/radiol.2501080833.
- Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98(6 Suppl):14K-20K. https://doi.org/10.1016/j.amjcard.2006.01.020.
- Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis. 2008;51(3):491-503. https://doi.org/10.1053/j.ajkd.2007.10.044.
- Katholi RE. Contrast-induced nephropathy-choice of contrast agents to reduce renal risk. Am Heart Hosp J. 2009;7(1):45-9. https://doi.org/10.15420/ahhj.2009.7.1.45.
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. https://doi.org/10.1159/000339789.
- Bugani G, Ponticelli F, Giannini F, Gallo F, Gaudenzi E, Laricchia A, et al. Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2021;97(3):443-50. https://doi.org/10.1002/ccd.28740.
- Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, et al. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Clin Exp Nephrol. 2020;24(1):1-44. https://doi.org/10.1007/s10157-019-01750-5.